» Articles » PMID: 20225037

Strategies to Insulate Lentiviral Vector-expressed Transgenes

Overview
Specialty Molecular Biology
Date 2010 Mar 13
PMID 20225037
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Lentiviruses are capable of infecting many cells irrespective of their cycling status, stably inserting DNA copies of the viral RNA genomes into host chromosomes. This property has led to the development of lentiviral vectors for high-efficiency gene transfer to a wide variety of cell types, from slowly proliferating hematopoietic stem cells to terminally differentiated neurons. Regardless of their advantage over gammaretroviral vectors, which can only introduce transgenes into target cells that are actively dividing, lentiviral vectors are still susceptible to chromosomal position effects that result in transgene silencing or variegated expression. In this chapter, various genetic regulatory elements are described that can be incorporated within lentiviral vector backbones to minimize the influences of neighboring chromatin on single-copy transgene expression. The modifications include utilization of strong internal enhancer-promoter sequences, addition of scaffold/matrix attachment regions, and flanking the transcriptional unit with chromatin domain insulators. Protocols are provided to evaluate the performance as well as the relative biosafety of lentiviral vectors containing these elements.

Citing Articles

Decoding RNA Metabolism by RNA-linked CRISPR Screening in Human Cells.

Nugent P, Park H, Wladyka C, Chen K, Bynum C, Quarterman G bioRxiv. 2024; .

PMID: 39091804 PMC: 11291135. DOI: 10.1101/2024.07.25.605204.


Advances in HIV Gene Therapy.

Kitawi R, Ledger S, Kelleher A, Ahlenstiel C Int J Mol Sci. 2024; 25(5).

PMID: 38474018 PMC: 10931721. DOI: 10.3390/ijms25052771.


Challenges in HIV-1 Latent Reservoir and Target Cell Quantification in CAR-T Cell and Other Lentiviral Gene Modifying HIV Cure Strategies.

Buck A, Deveau T, Henrich T, Deitchman A Viruses. 2023; 15(5).

PMID: 37243212 PMC: 10222761. DOI: 10.3390/v15051126.


Structural, functional, and immunogenicity implications of F9 gene recoding.

Katneni U, Alexaki A, Hunt R, Hamasaki-Katagiri N, Hettiarachchi G, Kames J Blood Adv. 2022; 6(13):3932-3944.

PMID: 35413099 PMC: 9278298. DOI: 10.1182/bloodadvances.2022007094.


Investigating the Barrier Activity of Novel, Human Enhancer-Blocking Chromatin Insulators for Hematopoietic Stem Cell Gene Therapy.

Papayanni P, Psatha N, Christofi P, Li X, Melo P, Volpin M Hum Gene Ther. 2021; 32(19-20):1186-1199.

PMID: 34477013 PMC: 9206477. DOI: 10.1089/hum.2021.142.


References
1.
Kim D, Uetsuki T, Kaziro Y, Yamaguchi N, Sugano S . Use of the human elongation factor 1 alpha promoter as a versatile and efficient expression system. Gene. 1990; 91(2):217-23. DOI: 10.1016/0378-1119(90)90091-5. View

2.
Mielke C, Kohwi Y, Kohwi-Shigematsu T, Bode J . Hierarchical binding of DNA fragments derived from scaffold-attached regions: correlation of properties in vitro and function in vivo. Biochemistry. 1990; 29(32):7475-85. DOI: 10.1021/bi00484a017. View

3.
Grez M, Akgun E, Hilberg F, Ostertag W . Embryonic stem cell virus, a recombinant murine retrovirus with expression in embryonic stem cells. Proc Natl Acad Sci U S A. 1990; 87(23):9202-6. PMC: 55132. DOI: 10.1073/pnas.87.23.9202. View

4.
Petersen R, Kempler G, Barklis E . A stem cell-specific silencer in the primer-binding site of a retrovirus. Mol Cell Biol. 1991; 11(3):1214-21. PMC: 369392. DOI: 10.1128/mcb.11.3.1214-1221.1991. View

5.
Niwa H, Yamamura K, Miyazaki J . Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene. 1991; 108(2):193-9. DOI: 10.1016/0378-1119(91)90434-d. View